Oligohidramnion

01Pathophysiology

Amniotic fluid volume is a dynamic balance governed primarily by two processes: fetal urination (the main contributor to amniotic fluid in the second and third trimesters) and fetal swallowing (the main route of fluid reabsorption). In the first trimester, amniotic fluid is largely a transudate from the fetal skin and the amnion itself. However, by 16 weeks of gestation, the fetal kidneys become the dominant source of amniotic fluid, and the fetal skin keratinizes, eliminating transdermal fluid transfer.

Oligohydramnios develops when there is either reduced production or increased loss of amniotic fluid. Reduced production occurs when fetal renal function is impaired, whether from structural anomalies like bilateral renal agenesis or posterior urethral valves, or from functional reduction in renal perfusion as seen in uteroplacental insufficiency. When the placenta fails to deliver adequate blood flow, the fetus redistributes cardiac output preferentially to the brain and heart at the expense of the kidneys and lungs. This "brain-sparing" redistribution leads to decreased renal perfusion, decreased urine output, and consequently decreased amniotic fluid.

Increased loss of amniotic fluid most commonly results from premature rupture of membranes (PROM), where fluid leaks through a defect in the chorioamniotic membranes. This is a clinical diagnosis often confirmed by pooling of fluid in the posterior vaginal fornix, a positive nitrazine test (turning blue due to alkaline pH of amniotic fluid), or ferning on microscopy.

The consequences of oligohydramnios depend on timing and severity. In early pregnancy (second trimester), severe oligohydramnios leads to pulmonary hypoplasia because the fetus lacks the fluid environment necessary for lung expansion and development. Fetal breathing movements against amniotic fluid are critical for alveolar growth. Without this, the lungs remain underdeveloped, which is often incompatible with postnatal life. Prolonged oligohydramnios also causes limb compression deformities and the characteristic Potter facies (flattened nose, recessed chin, low-set ears, epicanthal folds) due to mechanical compression from the uterine wall directly against the fetus.

In late pregnancy, oligohydramnios increases the risk of umbilical cord compression during labor. Without adequate fluid cushioning, the cord can become trapped between the fetus and the uterine wall, producing variable decelerations on fetal heart rate monitoring. This is the hallmark tracing pattern associated with oligohydramnios in labor.

Medications are a testable cause. NSAIDs (e.g., indomethacin used for tocolysis) cause oligohydramnios by decreasing fetal renal blood flow through prostaglandin inhibition. ACE inhibitors are teratogenic and reduce fetal renal perfusion, causing oligohydramnios, renal dysgenesis, and neonatal renal failure. Both drug classes are high-yield associations.

02Classification and Clinical Manifestation

Potter Sequence deserves emphasis as a distinct clinical entity. This is not a single disease but a sequence of deformations caused by severe, prolonged oligohydramnios regardless of the underlying etiology. The unifying mechanism is extrinsic compression of the fetus. The classic tetrad includes: (1) pulmonary hypoplasia (the usual cause of death), (2) Potter facies, (3) limb and growth abnormalities, and (4) the underlying renal or urinary tract pathology. The most classic cause tested on exams is bilateral renal agenesis, which is incompatible with life.

03Diagnostic Workup

The best initial test is always ultrasound with calculation of the amniotic fluid index. The AFI is measured by dividing the uterus into four quadrants and summing the deepest vertical pocket in each quadrant. An AFI below 5 cm, or a single deepest pocket less than 2 cm, defines oligohydramnios. This distinction matters because some institutions prefer the single deepest pocket method, and exam questions may use either threshold.

Once oligohydramnios is confirmed, the next step is determining the cause. A detailed anatomy scan should evaluate the fetal kidneys and bladder. Bilateral renal agenesis presents with absent kidneys bilaterally and a persistently empty bladder on serial imaging. Posterior urethral valves (seen exclusively in males) present with a distended, thick-walled bladder ("keyhole sign") and bilateral hydroureteronephrosis.

If the clinical picture suggests fluid leakage, a sterile speculum examination is performed to evaluate for PROM. Importantly, digital cervical exam should be avoided in suspected PROM because it increases the risk of introducing infection. The three confirmatory findings for PROM are pooling, nitrazine positivity, and ferning. If these are equivocal, AmniSure (detection of placental alpha microglobulin-1) or insulin-like growth factor binding protein-1 (IGFBP-1) testing can confirm the diagnosis.

Doppler velocimetry of the umbilical artery is indicated when uteroplacental insufficiency is suspected. Absent or reversed end-diastolic flow is an ominous finding that often prompts delivery regardless of gestational age.

A biophysical profile (BPP) integrates ultrasound assessment of amniotic fluid volume with fetal tone, movement, breathing, and a non-stress test. Oligohydramnios itself scores 0 out of 2 on the fluid component, and the combination of low fluid with absent fetal movement or breathing often triggers intervention.

04Management and Treatment

Maternal hydration is a simple but tested intervention. Oral hydration (approximately 2 liters of water over 2 hours) has been shown to increase AFI in cases of mild, idiopathic oligohydramnios or dehydration. This is a common "next best step" answer when the vignette describes borderline low fluid without an alarming underlying cause.

Amnioinfusion is the key intrapartum intervention. When oligohydramnios leads to recurrent variable decelerations during labor, the instillation of isotonic saline through an intrauterine pressure catheter restores fluid cushioning around the cord. This is a procedural concept that appears frequently. It is not used prophylactically in all oligohydramnios cases but rather when cord compression is demonstrated by the fetal heart rate pattern.

For preterm PROM, the management strategy hinges on gestational age. Between 24 and 34 weeks, expectant management is preferred as long as there is no evidence of chorioamnionitis, placental abruption, or non-reassuring fetal testing. Betamethasone is given for lung maturity. Latency antibiotics (the classic regimen is ampicillin 2 g IV every 6 hours for 48 hours, then amoxicillin 250 mg orally every 8 hours for 5 days, plus erythromycin or azithromycin) prolong the latency period and reduce neonatal morbidity. After 34 weeks, delivery is generally recommended because the risks of prematurity become lower than the risks of prolonged membrane rupture.

The management of drug-induced oligohydramnios is straightforward: stop the drug. Indomethacin, when used as a tocolytic, should generally not be continued beyond 32 weeks of gestation because of the risk of oligohydramnios and premature closure of the ductus arteriosus. ACE inhibitors and ARBs are contraindicated throughout pregnancy but cause renal effects predominantly in the second and third trimesters.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common trap with oligohydramnios questions is confusing the direction of the amniotic fluid abnormality. Students must memorize that fetal urinary tract problems cause low fluid (oligohydramnios) while fetal swallowing problems cause high fluid (polyhydramnios). The logic is intuitive once internalized: if the fetus cannot urinate, fluid is not added to the amniotic cavity; if the fetus cannot swallow, fluid is not removed. Esophageal atresia and anencephaly cause polyhydramnios. Renal agenesis and obstructive uropathy cause oligohydramnios.

Another frequent "gotcha" involves drug-induced oligohydramnios. A vignette may describe a pregnant woman treated with indomethacin for preterm labor who now has decreased amniotic fluid. The tested concept is recognizing the causal link between NSAIDs and reduced fetal urine output via prostaglandin inhibition. Similarly, any vignette mentioning ACE inhibitor or ARB use during pregnancy should immediately raise concern for oligohydramnios and fetal renal injury.

Students also commonly miss the Potter sequence connection. When a vignette describes a newborn with flattened facial features, limb deformities, and respiratory failure at birth, the unifying diagnosis is Potter sequence from bilateral renal agenesis, not a primary pulmonary or musculoskeletal disorder. The pulmonary hypoplasia is the consequence, not the primary problem.

Finally, the intrapartum management pearl: variable decelerations on fetal monitoring during labor in a patient with known oligohydramnios should prompt consideration of amnioinfusion. This is distinct from late decelerations (which suggest uteroplacental insufficiency and may require emergent delivery) and early decelerations (which are benign and caused by fetal head compression). The fetal heart rate pattern is the discriminator for the correct intervention.